Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial

Authors: José María Álvaro‐Gracia, Juan Ángel Jover, Rosario García‐Vicuña, Luis Carreño, Alberto Alonso, Sara Marsal, Francisco J. Blanco, Víctor M. Martínez‐Taboada, Peter C. Taylor, Cristina Martín-Martín, Olga DelaRosa, Ignacio Tagarro, Federico Díaz‐González - Annals of the Rheumatic Diseases 2016 cited by 263